Quarterly report · Q1
4078.TEDINET S100RJIK
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.1bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥83.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥932m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥926m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥878m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥454m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥565m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥131.4bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥128.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥127.2bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.9bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥84.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥84.0bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.8bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥28.04 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.4 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.64 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 61.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥569m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥19.1bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥247m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥54m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥60m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥21.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥21.1bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥302m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥558m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.8bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.5bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥360m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥74m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥89m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥21.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥21.4bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥435m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 367
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 89000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 2385000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -558000000 | JPY |
| Operating income | Prior1YTDDuration | 1826000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 19091000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 1995000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 21086000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 21086000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 247000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 54000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 302000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -302000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 19338000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 2050000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 21389000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -302000000 | JPY |
| Net sales | CurrentYTDDuration | 21086000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 1441000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 60000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1502000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -569000000 | JPY |
| Operating income | CurrentYTDDuration | 932000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-07 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第129期第１四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)堺化学工業株式会社 | |
| Company name in english cover page | FilingDateInstant | SAKAI CHEMICAL INDUSTRY CO., LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 矢倉 敏行 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)堺市堺区戎島町５丁２番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０７２（２２３）４１１１（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経理部長 服部 浩之 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区岩本町２丁目３番３号 ザイマックス岩本町ビル内 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０３（５８２３）３７２１（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京事務所長 後藤 幸辰 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00780 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 40780 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)堺化学工業株式会社 | |
| Filer name in english | FilingDateInstant | SAKAI CHEMICAL INDUSTRY CO., LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |